Articles & Research from Venn Life Sciences

Low dose Pipamperone significantly binds 5-HT2A receptor without clinically relevant D2 receptor binding: a PET study

Accelerated antidepressant effect of pipamperone characterized by non-linear mixed effect model

How to Assess the Speed of Antidepressant Effect: Insights From the PIPCIT Clinical Trial Program

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a New Direct Thrombin Inhibitor (DPOC-4088) After Single Oral Doses of Two Prolonged Release Formulations in Healthy Male Subjects (NCT01347203)

Interaction of Pipamperone, Citalopram, and Genetic Variables in the Prediction of Antidepressant Response

Phase III Dose Selection for PNB01, a Novel Fixed-Dose Combination Antidepressant Inducing a Faster and Sustained Response

Population PK/PD Modeling of a Hepatitis C NS3 Inhibitor

Evaluating Dosing Regimens of a Hepatitis C NS3 Inhibitor using PK/PD Modeling

« Previous 1 … 6 7 8 9 Next »